Gene · 57126
Papers3,864
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,864
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. | Nat Commun | 2024 | 38272918 | PubTator, text mining | PubMed |
| CD177 is a novel IgG Fc receptor and CD177 genetic variants affect IgG-mediated function. | bioRxiv | 2024 | 38260289 | PubTator, text mining | PubMed |
| Transcriptomic analysis of glucosidase II beta subunit (GluIIß) knockout A549 cells reveals its roles in regulation of cell adhesion molecules (CAMs) and anti-tumor immunity. | BMC Genomics | 2024 | 38245670 | PubTator, text mining | PubMed |
| The Identification Distinct Antiviral Factors Regulated Influenza Pandemic H1N1 Infection. | Int J Microbiol | 2024 | 38229736 | PubTator, text mining | PubMed |
| Analysis of Immune and Prognostic-Related lncRNA PRKCQ-AS1 for Predicting Prognosis and Regulating Effect in Sepsis. | J Inflamm Res | 2024 | 38229689 | PubTator, text mining | PubMed |
| Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker. | Discov Oncol | 2024 | 38227081 | PubTator, text mining | PubMed |
| The link between neutrophils, NETs, and NLRP3 inflammasomes: The dual effect of CD177 and its therapeutic potential in acute respiratory distress syndrome/acute lung injury. | Biomol Biomed | 2024 | 38226808 | PubTator, text mining | PubMed |
| Disease Activity and Tendency to Relapse in ANCA-Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies. | J Immunol Res | 2024 | 38213873 | PubTator, text mining | PubMed |
| Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub. | Int J Mol Sci | 2024 | 38203779 | PubTator, text mining | PubMed |
| Deciphering the prognostic significance of anoikis-related lncRNAs in invasive breast cancer: from comprehensive bioinformatics analysis to functional experimental validation. | Aging (Albany NY) | 2024 | 38189818 | PubTator, text mining | PubMed |
| Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes. | Ther Adv Hematol | 2024 | 38186638 | PubTator, text mining | PubMed |
| OMIP-100: A flow cytometry panel to investigate human neutrophil subsets. | Cytometry A | 2024 | 38179854 | PubTator, text mining | PubMed |
| Uncovering the flip side of immune checkpoint inhibitors: a comprehensive review of immune-related adverse events and predictive biomarkers. | Int J Biol Sci | 2024 | 38169638 | PubTator, text mining | PubMed |
| Programmable synthetic receptors: the next-generation of cell and gene therapies. | Signal Transduct Target Ther | 2024 | 38167329 | PubTator, text mining | PubMed |
| Metabolic switching, growth kinetics and cell yields in the scalable manufacture of stem cell-derived insulin-producing cells. | Stem Cell Res Ther | 2024 | 38167219 | PubTator, text mining | PubMed |
| Function and mechanism of GBP1 in the development and progression of cervical cancer. | J Transl Med | 2024 | 38167153 | PubTator, text mining | PubMed |
| Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis. | BMC Infect Dis | 2024 | 38166628 | PubTator, text mining | PubMed |
| C/EBPβ-induced lymphoid-to-myeloid transdifferentiation emulates granulocyte-monocyte progenitor biology. | Stem Cell Reports | 2024 | 38157851 | PubTator, text mining | PubMed |
| ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. | Proc Natl Acad Sci U S A | 2024 | 38154064 | PubTator, text mining | PubMed |
| Rapid conversion of porcine pluripotent stem cells into macrophages with chemically defined conditions. | J Biol Chem | 2024 | 38097188 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57126/papers?page=9